EP 4095136 A1 20221130 - SYNTHESIS AND USE OF CLASS OF RESPIRATORY SYNCYTIAL VIRUS INHIBITORS
Title (en)
SYNTHESIS AND USE OF CLASS OF RESPIRATORY SYNCYTIAL VIRUS INHIBITORS
Title (de)
SYNTHESE UND VERWENDUNG EINER KLASSE VON RESPIRATORISCHEN SYNCYTIALVIRUS-INHIBITOREN
Title (fr)
SYNTHÈSE ET UTILISATION D'UNE CLASSE D'INHIBITEURS DU VIRUS RESPIRATOIRE SYNCYTIAL
Publication
Application
Priority
- CN 202010075139 A 20200122
- CN 2021073042 W 20210121
Abstract (en)
The present disclosure provides the synthesis and application of respiratory syncytial virus inhibitor, being a compound of formula I or a pharmaceutically acceptable salt, ester, isomer, solvate, prodrug or isotope label thereof.Compared with the existing inhibitors, the compounds of formula I have the advantages of superior activity and higher exposure in vivo.
IPC 8 full level
C07D 417/14 (2006.01); A61K 31/554 (2006.01); A61P 11/00 (2006.01); A61P 31/14 (2006.01); C07D 417/04 (2006.01)
CPC (source: CN EP KR US)
A61K 31/554 (2013.01 - CN KR US); A61P 11/00 (2017.12 - EP KR); A61P 31/12 (2017.12 - CN EP); A61P 31/14 (2017.12 - EP KR US); C07D 417/04 (2013.01 - CN EP KR); C07D 417/14 (2013.01 - EP KR); C07D 487/10 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
EP 4095136 A1 20221130; EP 4095136 A4 20230705; CN 113149977 A 20210723; CN 115023423 A 20220906; JP 2023511152 A 20230316; KR 20220130761 A 20220927; US 2023090060 A1 20230323; WO 2021147947 A1 20210729
DOCDB simple family (application)
EP 21744323 A 20210121; CN 202010075139 A 20200122; CN 2021073042 W 20210121; CN 202180010637 A 20210121; JP 2022544247 A 20210121; KR 20227028783 A 20210121; US 202117790987 A 20210121